Metrics cut 1
- FY27 EBITDA guidance reduced to ~₹300 crores steady-state (from ₹400 crores earlier)
Event Participants
Executives
3 Satvik Jain, President; Pradeep Mukherjee, CFO; Sudarshan Ganpati, CEO
Analysts
5 Aditya, Individual Investor; Hari Kumar, Individual Investor; Khushi Solanki, Agarwal & Company; Madhur Rathi, Counter Cyclical Investment; Pujan Shah, Molecule Ventures
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Revenue | ₹542 crores | +14% YoY driven by 38% specialty growth; -11% QoQ due to one-time synthetic butyl inventory liquidation in Q4 and PVC plant shutdown |
| Specialty Chemicals Revenue | ₹177 crores | +38% YoY; 33% of total revenue; CPVC volumes +59% YoY, SIOP volumes +3% YoY |
| Basic Chemicals Revenue | ₹361 crores | -18% QoQ on Q4 exceptional synthetic butyl sale base effect; PVC volumes down 20% on West Asia crisis |
| EBITDA (incl. other income) | ₹41.4 crores | -28% YoY, -41% QoQ; Specialty EBITDA +20% YoY, +35% QoQ; Basic Chemicals EBITDA negative ₹14 crores |
| Basic Chemicals EBIT | -₹28 crores | PVC only loss-making segment; caustic soda, soda ash, synthetic rutile all profitable |
| PVC Contribution Swing | ~₹50-55 crores | QoQ swing in PVC contribution from Q4 profit to Q1 loss due to VCM unavailability, elevated input costs, duty suspension |
| Finance Cost | ₹14.8 crores | -2% YoY, -4% QoQ reflecting ongoing deleveraging |
| Depreciation | ₹26 crores | Broadly stable; marginal increase in line with project capitalization |
| Deferred Tax Adjustment | ₹34 crores | One-time reduction in net deferred tax liability from migration to new 25.17% tax regime (vs 34.9% old regime) |
Geographic & Segment Commentary
Specialty Chemicals (CPVC & SIOP): Revenue at ₹177 crores with EBITDA up ~20% YoY. CPVC volumes surged 59% post-expansion, while SIOP demand remained healthy across construction, infrastructure, and paints/coatings. Segment margins compressed to 29.1% from 33.6% (Q1 FY26) due to dynamic CPVC-VCM/PVC spreads and volatility in input costs, though management notes margins are inherently variable given integrated PVC-CPVC linkage.
Basic Chemicals (PVC, Caustic Soda, Soda Ash, Synthetic Rutile): Revenue ₹361 crores, down 18% QoQ with negative EBITDA of ₹14 crores, driven entirely by PVC losses. West Asia conflict constrained VCM availability and spiked prices, coinciding with temporary suspension of import duties that brought in cheaper imports. Caustic soda benefited from improved ECU realization on chlorine-neutral position; soda ash stable; synthetic rutile margins improved YoY on customer mix and better pricing.
Exports: ~60% of SIOP production exported to the US; 100% of synthetic butyl volumes exported. No tariff impact on DCW products. SIOP exports seasonally stronger in Q3/Q4; synthetic rutile supply scheduling is back-ended with higher-priced customer deliveries.
Company-Specific & Strategic Commentary
₹250 crore growth capex announced: Two-part program over next 2-3 years. First, SIOP expansion from ~30,000 tons to 45,000 tons per annum — Phase 1 adds 7,000 tons (completion Q4 FY28) with infrastructure sized for subsequent 8,000 tons; includes micronized value-added grades to improve mix and margins. Second, captive power infrastructure at Saupram facility targeted for Q4 FY28 to structurally lower power costs. Management targeting minimum incremental ROC of 20%.
Deleveraging milestone: Legacy long-term debt to be fully repaid during FY27; company expected to be effectively net debt-free by year-end before incremental borrowing for new projects. Cash flow discipline maintained with 5-10% of top line held as cash equivalents; new borrowing will be "a shade higher" than repayments of ~₹135 crores.
Leadership transition: Sudarshan Ganpati appointed CEO, bringing execution capabilities to translate growth strategy into operating performance as the company moves from "strengthening foundation to building for the next phase of growth."
Tax regime migration: Company shifted to new concessional tax regime (25.17% including surcharge/cess vs 34.9% old), enabling ₹34 crore reduction in net deferred tax liability via MAT credit set-off of 25% of regular tax liability.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| FY27 EBITDA | ~₹300 crores steady-state | Revised from earlier ₹400 crore target due to permanent CPBC spread contraction; Q1 had one-time capacity loss; assumes all four quarters at steady state |
| FY27 Overall Performance | Better than FY26 | Based on current visibility despite Q1 PVC disruption; VCM availability normalized, duties reinstated |
| Basic Chemicals | Break-even in Q2 FY27 | Assumes current normalcy holds; July still carried higher-cost inventory and duties restored mid-month |
| PVC Prices | ₹82-86/kg near-term | Import parity well above the ₹80 MIP floor; China logistics issues prevent lower offers |
| SIOP Realizations | ~₹80,000+/ton, 35-36% margins | Stable margins maintained; growth in volumes and value-added products |
| Net Debt Position | Effectively net debt-free by end FY27 | Legacy debt fully repaid during the year; new borrowings for capex slightly exceed repayments |
Risks & Constraints
| Risk | Context |
|---|---|
| VCM Supply & Price Volatility | Entire VCM requirement is imported (no merchant VCM producers in India). West Asia crisis caused force majeure for Asian producers and spot purchases from China at elevated prices. Management migrated from single-source Qatar supply to a global distributor to de-risk availability, but price shocks in geopolitical events cannot be hedged; backward integration not viable without 5x PVC capacity expansion. |
| CPVC-PVC Spread Lag | Rising PVC prices will compress PVC-CPVC spread with a lag; Q2 specialty margins expected to face contraction as old lower-priced orders are delivered. Net impact favorable since PVC capacity (1 lakh tons) is double CPVC capacity (50,000 tons). |
| Policy/Regulatory Reversals | Q1 saw temporary suspension of import duties on petrochemical products, flooding domestic market with cheaper imports and pressuring realizations. Duties reinstated and MIP introduced, but policy changes remain an external risk factor. |
| Competitive Exports from China | Chinese competitive exports continue to pressure pricing in commodity chemicals. MIP provides a floor of ₹80/kg, but structural competition remains. |
| Q2 Sticky Costs | July carried higher-cost inventory and duties were not restored for major part of the month, so Q2 improvement builds through August-September rather than being immediate. |
Q&A Highlights
Revenue Decline Decomposition
- Question: How much of the sequential revenue decline was due to captive PVC consumption for CPVC, lower PVC production, and synthetic butyl inventory liquidation? (Aditya, Individual Investor)
- Answer: The synthetic butyl Q4 inventory liquidation was the single largest factor — "single-handedly impacted" — plus a few days of PVC plant shutdown; specific split not quantified. (Pradeep Mukherjee, CFO)
Specialty Segment Margin Compression
- Question: EBITDA grew only 19.2% YoY vs revenue growth of 38% YoY; margins fell from 33.6% to 29.1%. Is 29% the new normalized level? (Aditya, Individual Investor)
- Answer: Margins are inherently dynamic because 40-50% of PVC production feeds CPVC, and CPVC spreads follow PVC/VCM with volatility driven by import duty changes. SIOP margins remain robust. "Difficult to tell a steady-state margin" given the integration. (Pradeep Mukherjee, CFO)
PVC Loss Quantification & Q2 Recovery
- Question: Can you quantify the PVC losses, since caustic, soda ash, and synthetic rutile were profitable? (Madhur Rathi, Counter Cyclical Investment)
- Answer: The contribution swing from Q4 to Q1 in PVC is estimated at ~₹50-55 crores. "We more than believe" basic chemicals will break even in Q2 if current normalcy holds. (Pradeep Mukherjee, CFO)
FY27 EBITDA Target Revision
- Question: Does the ₹400 crore EBITDA target still stand for FY27? (Madhur Rathi, Counter Cyclical Investment)
- Answer: No — the ₹400 crore target assumed 40% CPBC margins which have structurally contracted. Revised steady-state assessment is ~₹300 crores EBITDA, and "you should assess us at ₹300 crores" for FY27. (Pradeep Mukherjee, CFO)
Share Buyback Consideration
- Question: With stock at ₹44 (same as 2007), net debt-free position, and new SEBI open-market buyback rules (no premium, but promoter participation excluded), doesn't buyback make compelling sense? (Madhur Rathi, Counter Cyclical Investment)
- Answer: "We are mulling on this idea... we will announce it in an opportune time if we at all decide to do so." (Pradeep Mukherjee, CFO)
PVC Prices & MIP Impact
- Question: With MIP at ~₹80, have PVC prices bottomed at ₹85-87? (Pujan Shah, Molecule Ventures)
- Answer: MIP translates to ₹80 as the bottom, but current import offers are ₹82-86 — well above MIP. China is the only low-cost supplier, but logistics issues prevent market flooding. PVC-VCM spread should benefit Q2, though July carried higher-cost inventory and duties weren't restored for most of July. Improvement builds from August. (Pradeep Mukherjee, CFO)
CapEx Funding & Leverage
- Question: Will the ₹250 crore capex need debt, given Q1 weakness? (Pujan Shah, Molecule Ventures)
- Answer: Repayments ~₹135 crores; borrowing will be "a shade higher" to fund capex while maintaining 5-10% of top line as cash. Negative carry of 1-1.5% between cash yields and borrowing costs is acceptable. SIOP commissioning targeted Q4 FY28 with immediate commercialization given product expertise; Phase 2 decision after H1 FY28. (Pradeep Mukherjee, CFO)
VCM Procurement De-Risking
- Question: Is the West Asia impact on VCM logistics or actual supply shortage, and what's the de-risking strategy? (Khushi Solanki, Agarwal & Company)
- Answer: Actual supply shortage — Asian producers faced force majeure on Middle East feedstocks; DCW bought from China at spot premium. Company migrated from single-source Qatar supply to a global distributor sourcing from different Asian producers, which "de-risked supplies big time." Price risk in war scenarios can't be planned for; no backward integration viable at current scale (requires 5x PVC capacity). (Pradeep Mukherjee, CFO)
Chemistry Strategy & Expansion Logic
- Question: With stronger cash generation and conservative expansion plans, will DCW diversify into unrelated chemicals? (Hari Kumar, Individual Investor)
- Answer: Growth stays in related chemistry — the SIOP expansion leverages existing moats (high capital entry barriers, established US customer base, global market). "We are not getting into unrelated chemistry at the moment because we don't think we have exhausted the opportunity in the related chemistry." (Pradeep Mukherjee, CFO)
VCM Storage as Hedge
- Question: Can increased VCM storage capacity de-risk supply disruptions? (Hari Kumar, Individual Investor)
- Answer: Storage would add only 10-15 days of buffer, and VCM is gaseous (expensive to store); "it's a supply chain play, not a de-risking play." Sourcing diversification via global distributor is the effective solution. (Pradeep Mukherjee, CFO)
Key Takeaway
DCW Ltd's Q1 FY27 was hit by event-driven PVC disruption — revenue at ₹542 crores (+14% YoY) but EBITDA dropped to ₹41.4 crores (-28% YoY) as the West Asia crisis constrained VCM supply, spiked input costs, and the temporary import duty suspension crushed PVC realizations, turning Basic Chemicals EBITDA negative at ₹14 crores. Specialty Chemicals proved resilient with EBITDA up 20% YoY on 59% CPVC volume growth, and caustic soda, soda ash, and synthetic rutile remained profitable. Management revised steady-state EBITDA guidance down to ~₹300 crores (from ₹400 crores) but expects Q2 break-even in Basic Chemicals on normalized VCM prices, reinstated duties, and the new ₹80 MIP floor. The company announced a ₹250 crore growth capex — SIOP expansion from 30,000 to 45,000 tons and captive power infrastructure — targeting 20%+ incremental ROC, while projecting net debt-free status by FY27 end. Key watch points: Q2 CPVC-PVC spread lag, sustained PVC pricing above MIP, and execution of Phase 1 SIOP commissioning by Q4 FY28.